Abstract 62: Development of dual-targeted fine-tuned immune restoring (DFIR) CAR T cell therapy for clear cell renal cell carcinoma (ccRCC)Yufei Wang, Wayne A. Marasco, Marion Grimaud et al.|Cancer Research|2021Cited by 3